Zeal, Novelty, Spirit: The Siba Life Sciences Ltd. prelude

Pharmaceuticals

  • Our brand portfolio targets chronic diseases from diabetes, cancer, and end- stage renal illnesses to immune disorders and other life-threatening conditions
  • Marketed primarily in India, parts of Asia, Middle East and Africa, we offer our products to healthcare providers, including physicians, clinics, hospitals and pharmacies.
  • Beyond therapy, we support select products with patient friendly initiatives in disease awareness, prevention and management.
  • We also assist healthcare professionals and patients with the treatment of complex medical conditions.